ArchPoint Investors’s Rocket Pharmaceuticals RCKT Stock Holding History

ArchPoint Investors’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,000	Closed	-$32.6K	–	82
2025 Q3	$32.6K	Buy	+10,000	New	+$31.5K	0.01%	72
2020 Q3	–	Sell	-1,500	Closed	-$31K	–	119
2020 Q2	$31K	Hold	1,500	–	–	0.01%	107
2020 Q1	$21K	Hold	1,500	–	–	0.01%	127
2019 Q4	$34K	Hold	1,500	–	–	0.01%	124
2019 Q3	$17K	Buy	+1,500	New	+$18.6K	0.01%	129

Other funds holding RCKT

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Citigroup New York $157B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return

Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return